Trellis selects CMC Biologics to make mAb therapies
CMC Biologics and Trellis Bioscience are teaming up to make monoclonal antibody (mAb)-based therapies.
Archives for August 7, 2017
update
Hep B vaccine supply issues at Merck & Co and GSK prompt UK to prioritize access
Public Health England has reserved NHS hepatitis B vaccine stocks for people at high risk of infection, citing shortages caused by production interruptions at Merck & Co and GSK.